Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study.
文献类型：期刊论文
| 作者 | Chen, Zhanhong; Wang, Xiaojia; Huang, Jian; Zheng, Yabing; Shao, Xiying; Cao, Wenming; Chen, Junqing; Ye, Weiwu; Ping, Huang; Li, Guangliang |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2022-06-01 |
| 卷号 | 40 |
| ISSN号 | 0732-183X |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000863680300244 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129927]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Med Oncol Breast, Hangzhou, Peoples R China 2.Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Peoples R China 3.Zhejiang Canc Hosp, Hangzhou, Peoples R China 4.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 5.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Canc & Basic Med ICBM, Chinese Acad Sci,Dept Breast Med Oncol,Canc Hosp, Hangzhou, Peoples R China 6.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 7.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Breast Med Oncol, Hangzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Chen, Zhanhong,Wang, Xiaojia,Huang, Jian,et al. Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
| APA | Chen, Zhanhong.,Wang, Xiaojia.,Huang, Jian.,Zheng, Yabing.,Shao, Xiying.,...&Lou, Caijin.(2022).Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study..JOURNAL OF CLINICAL ONCOLOGY,40. |
| MLA | Chen, Zhanhong,et al."Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study.".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。